All patients | Time to ART initiation: ≤14 days | Time to ART initiation: 15 to 28 days | Time to ART initiation: 29 to 60 days | Time to ART initiation: 61 to 90 days | Time to ART initiation: 91 to 180 days | Time to ART initiation: 181 to 360 days | Time to ART initiation: >360 days | |
---|---|---|---|---|---|---|---|---|
(N = 1022) | (N = 132) | (N = 102) | (N = 143) | (N = 51) | (N = 122) | (N = 114) | (N = 358) | |
Age at HIV diagnosis (years), mean ± SD [median] | 40.0 ± 11.9 [40.9] | 40.4 ± 11.7 [41.7] | 40.2 ± 12.3 [41.4] | 39.1 ± 13.7 [39.8] | 41.1 ± 13.2 [41.5] | 40.9 ± 11.9 [40.5] | 40.2 ± 11.5 [40.8] | 39.6 ± 11.0 [40.7] |
Range (years) | (18.0 to 70.0) | (18.2 to 66.6) | (18.3 to 65.7) | (18.0 to 65.3) | (18.2 to 63.9) | (18.0 to 62.6) | (18.0 to 70.0) | (18.0 to 66.1) |
Female, n (%) | 451 (44.1%) | 57 (43.2%) | 51 (50.0%) | 53 (37.1%) | 22 (43.1%) | 52 (42.6%) | 49 (43.0%) | 167 (46.6%) |
Race, n (%) | ||||||||
White | 248 (24.3%) | 35 (26.5%) | 30 (29.4%) | 39 (27.3%) | 7 (13.7%) | 23 (18.9%) | 33 (28.9%) | 81 (22.6%) |
Black | 582 (56.9%) | 72 (54.5%) | 47 (46.1%) | 78 (54.5%) | 35 (68.6%) | 76 (62.3%) | 54 (47.4%) | 220 (61.5%) |
Other | 192 (18.8%) | 25 (18.9%) | 25 (24.5%) | 26 (18.2%) | 9 (17.6%) | 23 (18.9%) | 27 (23.7%) | 57 (15.9%) |
Patients who initiated a single‐tablet regimen, n (%) | 592 (57.9%) | 82 (62.1%) | 60 (58.8%) | 81 (56.6%) | 26 (51.0%) | 72 (59.0%) | 65 (57.0%) | 206 (57.5%) |
Patients with ≥1 diagnosis of an opportunistic infection between diagnosis and ART initiation, n (%) | 69 (6.8%) | 6 (4.5%) | 7 (6.9%) | 7 (4.9%) | 1 (2.0%) | 9 (7.4%) | 11 (9.6%) | 28 (7.8%) |
Patients with ≥1 emergency room between diagnosis and ART initiation, n (%) | 438 (42.9%) | 8 (6.1%) | 11 (10.8%) | 31 (21.7%) | 12 (23.5%) | 46 (37.7%) | 61 (53.5%) | 269 (75.1%) |
Patients with ≥1 inpatient visit between diagnosis and ART initiation, n (%) | 362 (35.4%) | 12 (9.1%) | 26 (25.5%) | 39 (27.3%) | 18 (35.3%) | 36 (29.5%) | 43 (37.7%) | 188 (52.5%) |